Myelo Therapeutics GmbH
Research - Berlin, Berlin, Germany
Myelo Therapeutics GmbH Employees
Myelo Therapeutics GmbH Details
Myelo Therapeutics GmbH develops innovative treatments in areas of high unmet medical needs. Its lead compound, myelo001, is a small molecule that is effective on the hematogenesis. Its oral application is being investigated as a treatment for - chemotherapy-induced myelosuppression (CIM), including chemotherapy-induced neutropenia (CIN), chemotherapy-induced thrombocytopenia, and chemotherapy-induced lymphocytopenia- radiation-induced myelosuppression (RIM) - acute radiation syndrome (ARS).
Website:
http://www.myelotherapeutics.com
Employees:
11
HQ:
+49 30 68908696
Location:
Berlin, Berlin, Germany
Revenue:
Myelo Therapeutics GmbH Technologies
Load Balancers
Apache
CSS and JavaScript Libraries
Bootstrap Framework
Other
Mobile Friendly